Drug Development in India

Novartis Global Drug Development (GDD) delivers successful innovations to improve patients’ lives. We lead the industry in R&D investment and in the number of approvals from regulatory bodies, and are recognized and respected for the quality of our work.

India hosts one of the three global drug development centers for Novartis worldwide. We combine deep therapeutic area knowledge with advanced, integrated data analytics to drive an agile approach to drug development. We support critical components of the drug development process across the broad, integrated pipeline of Novartis including pharmaceuticals, cancer treatments, generics, and biosimilars.

We have integrated development capabilities and a strong operational footprint across all major drug development areas such as clinical development, data analysis, electronic data management, clinical operations, regulatory affairs, pharmacovigilance, and technical research & development. At our government recognized R&D center in Hyderabad, we carry out technical and analytical research and development work including testing and analysis of drug formulations. We also play a critical role in our global strategy to bring life-saving medicines to market by supporting regulatory filings.

We provide our associates an environment in which they can thrive and contribute towards changing the practice of medicine. Associates at Novartis have the opportunity to work on global project teams with top-notch scientists.

Our continuous endeavor is to improve and extend people’s lives by maintaining our lead in science and operations, attracting and nurturing the best talent, and driving innovation in development of life-saving medicines for Novartis globally.